Assessing antimicrobial resistance connectivity across One Health sectors

  • Liguan LI
  • , Bing Li
  • , Xiaole Yin
  • , Yu Xia
  • , Yu Yang
  • , Xiaoqing Xu
  • , Tommy Tsan Yuk Lam
  • , Kenneth M.Y. Leung
  • , Fujie Xu
  • , Xuxiang Zhang
  • , Jianhua Guo
  • , Heike Schmitt
  • , Gerard D. Wright
  • , Janet Midega
  • , Carlos Bezuidenhout
  • , Renata C. Picão
  • , Shaikh Z. Ahammad
  • , Kornelia Smalla
  • , Steven P. Djordjevic
  • , Amy Pruden
  • Peter Vikesland, Dominic Frigon, Fiona Walsh, Thomas U. Berendonk, Gianluca Corno, Despo Fatta-Kassinos, Chang Jun Cha, Nicholas Ashbolt, Guangguo Ying, Yi Luo, Yang Wang, Jianzhong Shen, Yu Zhang, Min Yang, Xiangdong Li, Baolan Hu, Lizhong Zhu, Yongning Wu, Song Tang, Biao Kan, Yong Guan Zhu, Barth F. Smets, David Graham, Ryo Honda, Eddie Cytryn, Erica Donner, Per Halkjær Nielsen, Mark van Loosdrecht, Michael R. Gillings, William Gaze, Célia M. Manaia, Pedro J.J. Alvarez, Martin J. Blaser, Edward Topp, Tong Zhang

Research output: Contribution to journalArticlespeer-review

1 Citation (Scopus)

Abstract

The first therapeutic use of antimicrobial agents initiated their endless arms race with antimicrobial resistance (AMR). Although the genes encoding antimicrobial resistance are ancient and ubiquitous in various environmental compartments, including aquatic environments, over eight decades of exposure to selective pressure has changed the way antimicrobial resistance genes (ARGs) emerge and transmit among the three One Health sectors (that is, the intersected sectors of humans, animals and the environment). The dissemination of ARGs has been facilitated by the widespread use of antimicrobials, along with direct and secondary pollution pathways. Current global consensus dictates that AMR should be addressed under a One Health framework. AMR National Action Plans have frequently been formulated. However, the capacity for implementation is not ready in most countries, especially in low- and middle-income regions. This is in part due to the substantial challenges in documenting and controlling cross-sector AMR connectivity. Here we describe the past and current status of AMR, emphasizing the contribution of connectivity to global AMR burden. We discuss connectivity at ecological, microbial and genetic levels; propose an approach based on genomics and metagenomics to assess connectivity; and finally advocate for cross-sector studies to better understand AMR connectivity and mitigate dissemination. We believe that such harmonized connectivity studies will facilitate coordinated actions and investments across sectors and regions to scale up AMR management globally. Copyright © 2025 Springer Nature Limited.

Original languageEnglish
Pages (from-to)1100-1113
JournalNature Water
Volume3
DOIs
Publication statusPublished - Sept 2025

Citation

Li, L., Li, B., Yin, X., Xia, Y., Yang, Y., Xu, X., Lam, T. T.-Y., Leung, K. M. Y., Xu, F., Zhang, X., Guo, J., Schmitt, H., Wright, G. D., Midega, J., Bezuidenhout, C., Picão, R. C., Ahammad, S. Z., Smalla, K., Djordjevic, S. P., . . . Zhang, T. (2025). Assessing antimicrobial resistance connectivity across One Health sectors. Nature Water, 3, 1100-1113. https://doi.org/10.1038/s44221-025-00514-8

Fingerprint

Dive into the research topics of 'Assessing antimicrobial resistance connectivity across One Health sectors'. Together they form a unique fingerprint.